PORT WASHINGTON, N.Y., Dec. 3, 2025 /PRNewswire/ -- EQUASHIELD ®, a global leader in Closed System Transfer Devices (CSTD) and pharmacy automation, will highlight its fully integrated hazardous drug ...
PORT WASHINGTON, N.Y., May 22, 2025 /PRNewswire/ -- EQUASHIELD ®, a global leader in Closed System Transfer Devices (CSTDs) and automated compounding solutions, proudly announces that it has been ...
Equashield, a leading provider of Closed System Transfer Devices (CSTD) for safe and simple handling of hazardous drugs, announced today that it is expanding its range of solutions and products ...
Equashield Begins Implementations of Closed System Compounding Robots in Major International Markets
Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, announced today it has received its first purchase orders for its Equashield Pro closed ...
The deal puts Equashield at a valuation of $300 million Equashield was founded in 2009 Since inception in 1989, Nordic Capital has invested more than 20 billion euros in equity capital in over 125 ...
Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, announced today a distribution partnership with Saudi Arabia-based Max Care Medical. Max ...
As clinicians become more comfortable with the idea of robots in the care setting, more companies are exploring ways to break into the growing hospital robotics market, which is expected to reach ...
Equashield, a leading provider of Closed System Transfer Devices (CSTDs) for safe and simple handling of hazardous drugs, today announced a more than doubling of year-over-year revenue. Equashield ...
The MarketWatch News Department was not involved in the creation of this content. PORT WASHINGTON, N.Y., Dec. 3, 2025 /PRNewswire/ -- EQUASHIELD(R) , a global leader in Closed System Transfer Devices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results